propranolol has been researched along with Depression in 76 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The prevalence of PTSD, anxiety, and depression was similar in children who received propranolol acutely and those who did not." | 9.27 | Does Acute Propranolol Treatment Prevent Posttraumatic Stress Disorder, Anxiety, and Depression in Children with Burns? ( Herndon, DN; Holzer, CE; Humphries, HF; Meyer, WJ; Rosenberg, L; Rosenberg, M; Sharp, S; Thomas, CR, 2018) |
| " Of these 11 (not taking propranolol), nine (82 percent) developed postsurgical dissatisfaction syndrome." | 9.14 | Preventing postsurgical dissatisfaction syndrome after rhinoplasty with propranolol: a pilot study. ( Gruber, RP; Pitman, RK; Roberts, C; Schooler, W, 2009) |
| "We sought to determine whether propranolol has adverse effects on cognitive function, depressive symptoms, and sexual function in patients treated for diastolic hypertension." | 9.09 | The effects of propranolol on cognitive function and quality of life: a randomized trial among patients with diastolic hypertension. ( Acree, M; Baron, RB; Coates, TJ; Gardiner, PS; Halliday, R; Hauck, WW; Pérez-Stable, EJ, 2000) |
| "The response to diazepam and propranolol hydrochloride was compared in 21 patients who (with one exception) met DSM-III criteria for panic disorder and agoraphobia." | 9.05 | Diazepam and propranolol in panic disorder and agoraphobia. ( Anderson, DJ; Clancy, J; Crowe, RR; Ghoneim, MM; Hinrichs, JV; Noyes, R; Slymen, DJ, 1984) |
| "Since 1964, of 725 patients presenting with anxiety syndromes, 513 were treated with propranolol for periods of several days to over 10 years, some intermittently, others virtually without interruption." | 9.04 | Propranolol in the treatment of anxiety. ( Suzman, MM, 1976) |
| "This international postmarketing observational study of flunarizine was designed to evaluate, in routine clinical practice, the risk/benefit ratio of flunarizine in its approved indications, namely prophylaxis of migraine and treatment of vertigo." | 7.69 | Postmarketing study of the use of flunarizine in vestibular vertigo and in migraine. ( Amery, WK; De Locht, P; Verspeelt, J, 1996) |
| "The prevalence of PTSD, anxiety, and depression was similar in children who received propranolol acutely and those who did not." | 5.27 | Does Acute Propranolol Treatment Prevent Posttraumatic Stress Disorder, Anxiety, and Depression in Children with Burns? ( Herndon, DN; Holzer, CE; Humphries, HF; Meyer, WJ; Rosenberg, L; Rosenberg, M; Sharp, S; Thomas, CR, 2018) |
| " Of these 11 (not taking propranolol), nine (82 percent) developed postsurgical dissatisfaction syndrome." | 5.14 | Preventing postsurgical dissatisfaction syndrome after rhinoplasty with propranolol: a pilot study. ( Gruber, RP; Pitman, RK; Roberts, C; Schooler, W, 2009) |
| "We sought to determine whether propranolol has adverse effects on cognitive function, depressive symptoms, and sexual function in patients treated for diastolic hypertension." | 5.09 | The effects of propranolol on cognitive function and quality of life: a randomized trial among patients with diastolic hypertension. ( Acree, M; Baron, RB; Coates, TJ; Gardiner, PS; Halliday, R; Hauck, WW; Pérez-Stable, EJ, 2000) |
| "After 4 days of drug treatment with comparable doses of propranolol (40 and 80 mg), metoprolol (50 and 100 mg), or placebo, mood (POMS) and anxiety states (STAI) were assessed in healthy volunteers, before and after 1 h of treadmill walking exercise at 50% maximum oxygen uptake." | 5.08 | Acute effects of beta blockade and exercise on mood and anxiety. ( Eagles, C; Ferner, R; Head, A; Kendall, MJ, 1996) |
| "The response to diazepam and propranolol hydrochloride was compared in 21 patients who (with one exception) met DSM-III criteria for panic disorder and agoraphobia." | 5.05 | Diazepam and propranolol in panic disorder and agoraphobia. ( Anderson, DJ; Clancy, J; Crowe, RR; Ghoneim, MM; Hinrichs, JV; Noyes, R; Slymen, DJ, 1984) |
| "Since 1964, of 725 patients presenting with anxiety syndromes, 513 were treated with propranolol for periods of several days to over 10 years, some intermittently, others virtually without interruption." | 5.04 | Propranolol in the treatment of anxiety. ( Suzman, MM, 1976) |
| "We studied the occurrence of depression in new users of propranolol (n = 704), other beta-blockers (n = 587), angiotensin-converting enzyme inhibitors (n = 976), calcium channel blockers (n = 742), and diuretics (n = 773) in the Harvard Community Health Plan population." | 3.69 | The incidence of depression in new users of beta-blockers and selected antihypertensives. ( Bauer, M; Cho, P; Gerstman, BB; Jolson, HM; Livingston, JM; Platt, R, 1996) |
| "This international postmarketing observational study of flunarizine was designed to evaluate, in routine clinical practice, the risk/benefit ratio of flunarizine in its approved indications, namely prophylaxis of migraine and treatment of vertigo." | 3.69 | Postmarketing study of the use of flunarizine in vestibular vertigo and in migraine. ( Amery, WK; De Locht, P; Verspeelt, J, 1996) |
| "After chronic administration of propranolol (1 and 5 mg/kg, 14 days) to rats time-course of forced swimming changed with the decrease of rhythmical index of depression." | 3.68 | [The antidepressive properties of anaprilin]. ( Arushanian, EB; Beĭer, EV, 1992) |
| "A patient developed severe anxiety, moodswing, depression, and thinking disorder 24 hours after abruptly stopping oxazepam, of which he had taken 30 mg 3 times a day for two months, for anxiety and panic attacks." | 3.66 | Abstinence syndrome from therapeutic doses of oxazepam. ( Kulik, AV; Wilbur, R, 1983) |
| "Suicidal ideation was significantly associated with clinician observed akathisia, depressed mood, younger age, and use of propranolol." | 2.77 | Akathisia and suicidal ideation in first-episode schizophrenia. ( Gaebel, W; Gastpar, M; Heuser, I; Jäger, M; Klingenberg, S; Klosterkötter, J; Lewitzka, U; Maier, W; Mayr, A; Möller, HJ; Musil, R; Ohmann, C; Riedel, M; Schennach, R; Schlösser, R; Schmitt, A; Schneider, F; Seemüller, F, 2012) |
| "Propranolol was somewhat better than flunarizine in reducing the severity of migraine attacks, although this may have been due to a selection bias." | 2.68 | Post-marketing cohort study comparing the safety and efficacy of flunarizine and propranolol in the prophylaxis of migraine. ( Amery, WK; De Locht, P; Verspeelt, J, 1996) |
| "Monitoring for adverse effects in an integral part of controlled clinical trials." | 2.66 | Survival analysis of adverse effects data in the Beta-Blocker Heart Attack Trial. ( Davis, BR; Furberg, CD; Williams, CB, 1987) |
| " Other reported effects are toxic confusional states and psychotic reactions." | 2.36 | Psychiatric side effects of antihypertensive drugs other than reserpine. ( Fleminger, R; Paykel, ES; Watson, JP, 1982) |
| "Depression is a commonly cited adverse effect of β-blockers but the evidence for a causal relationship is limited." | 1.72 | β-Blockers and the Risk of Depression: A Matched Case-Control Study. ( Bornand, D; Jick, SS; Meier, CR; Reinau, D, 2022) |
| "Depression is a multifaceted psychological disorder that involves changes in behavior, neuroendocrine function, and physiological responses." | 1.32 | Behavioral and cardiovascular changes in the chronic mild stress model of depression. ( Beltz, TG; Grippo, AJ; Johnson, AK, 2003) |
| "We report on four cases of primary orthostatic tremor." | 1.31 | [Primary orthostatic tremor: report of 4 cases]. ( Cavallazzi, LO; Machado, SN; Matosinho, P; Pio, FJ, 2000) |
| "Successful migraine relief was achieved with a combination of propranolol and naproxen, administered before and after ECT." | 1.31 | Successful use of propranolol in migraine associated with electroconvulsive therapy. ( Delva, NJ; Hawken, ER; Lawson, JS, 2001) |
| "Bupropion is a novel antidepressant, distinct from tricyclic antidepressants both neurochemically and behaviorally." | 1.28 | Antidepressant profile of bupropion and three metabolites in mice. ( Colin, JN; Lacomblez, L; Martin, P; Massol, J; Puech, AJ, 1990) |
| " Although there was no correlation between propranolol dosage and depressive symptoms for the population as a whole, among patients with a negative history there was a highly significant positive correlation between propranolol dosage and depression scores." | 1.27 | Depressive symptoms in propranolol users. ( Friedman, MJ; Griffin, SJ, 1986) |
| "In 11 patients with chronic renal failure serum 3'-T1 levels were highly increased 285 pmol/l (115 - 1538 pmol/l) (P less than 0." | 1.26 | Serum 3'-monoiodothyronine levels in normal subjects and in patients with thyroid and non-thyroid disease. ( Cohn, D; Faber, J; Friis, T; Kirkegaard, C; Kølendorf, K; Lumholtz, IB; Siersbaek-Nielsen, K; Thomsen, HF, 1981) |
| "Propranolol was effective in treating acute pathological panic, but modest doses of the drug administered for brief periods of time did not alleviate chronic panic attacks associated with agoraphobia." | 1.26 | The treatment of pathological panic states with propranolol. ( Defrancisco, D; Heiser, JF, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 42 (55.26) | 18.7374 |
| 1990's | 10 (13.16) | 18.2507 |
| 2000's | 11 (14.47) | 29.6817 |
| 2010's | 11 (14.47) | 24.3611 |
| 2020's | 2 (2.63) | 2.80 |
| Authors | Studies |
|---|---|
| Czopek, A | 1 |
| Bucki, A | 1 |
| Kołaczkowski, M | 1 |
| Zagórska, A | 1 |
| Drop, M | 1 |
| Pawłowski, M | 1 |
| Siwek, A | 1 |
| Głuch-Lutwin, M | 1 |
| Pękala, E | 1 |
| Chrzanowska, A | 1 |
| Struga, M | 1 |
| Partyka, A | 1 |
| Wesołowska, A | 1 |
| Bornand, D | 1 |
| Reinau, D | 1 |
| Jick, SS | 1 |
| Meier, CR | 1 |
| Lanfranconi, S | 1 |
| Scola, E | 1 |
| Bertani, GA | 1 |
| Zarino, B | 1 |
| Pallini, R | 1 |
| d'Alessandris, G | 1 |
| Mazzon, E | 1 |
| Marino, S | 1 |
| Carriero, MR | 1 |
| Scelzo, E | 1 |
| Faragò, G | 1 |
| Castori, M | 1 |
| Fusco, C | 1 |
| Petracca, A | 1 |
| d'Agruma, L | 1 |
| Tassi, L | 1 |
| d'Orio, P | 1 |
| Lampugnani, MG | 1 |
| Nicolis, EB | 1 |
| Vasamì, A | 1 |
| Novelli, D | 1 |
| Torri, V | 1 |
| Meessen, JMTA | 1 |
| Al-Shahi Salman, R | 1 |
| Dejana, E | 1 |
| Latini, R | 1 |
| Siddiqui, PJA | 1 |
| Khan, A | 1 |
| Uddin, N | 1 |
| Khaliq, S | 1 |
| Rasheed, M | 1 |
| Nawaz, S | 1 |
| Hanif, M | 1 |
| Dar, A | 1 |
| Rosenberg, L | 1 |
| Rosenberg, M | 1 |
| Sharp, S | 1 |
| Thomas, CR | 1 |
| Humphries, HF | 1 |
| Holzer, CE | 1 |
| Herndon, DN | 1 |
| Meyer, WJ | 1 |
| Demir Özkay, Ü | 1 |
| Yurttaş, L | 1 |
| Özkay, Y | 1 |
| Üçel, UI | 1 |
| Can, ÖD | 1 |
| Öztürk, Y | 1 |
| Chen, HH | 1 |
| Yeh, SY | 1 |
| Lin, CL | 1 |
| Chang, SN | 1 |
| Kao, CH | 1 |
| Salviz, M | 1 |
| Yuce, T | 1 |
| Acar, H | 1 |
| Karatas, A | 1 |
| Acikalin, RM | 1 |
| Johnell, K | 1 |
| Fastbom, J | 1 |
| Zhang, HT | 1 |
| Whisler, LR | 1 |
| Huang, Y | 1 |
| Xiang, Y | 1 |
| O'Donnell, JM | 1 |
| Gruber, RP | 1 |
| Roberts, C | 1 |
| Schooler, W | 1 |
| Pitman, RK | 1 |
| Rothwell, PE | 1 |
| Thomas, MJ | 1 |
| Gewirtz, JC | 1 |
| Jesse, CR | 1 |
| Wilhelm, EA | 1 |
| Bortolatto, CF | 1 |
| Nogueira, CW | 1 |
| Yi, LT | 1 |
| Xu, HL | 1 |
| Feng, J | 1 |
| Zhan, X | 1 |
| Zhou, LP | 1 |
| Cui, CC | 1 |
| Hadj-Rabia, S | 1 |
| Lee, LY | 1 |
| Abbott, L | 1 |
| Mahlangu, B | 1 |
| Moodie, SJ | 1 |
| Anderson, S | 1 |
| Seemüller, F | 1 |
| Schennach, R | 1 |
| Mayr, A | 1 |
| Musil, R | 1 |
| Jäger, M | 1 |
| Maier, W | 1 |
| Klingenberg, S | 1 |
| Heuser, I | 1 |
| Klosterkötter, J | 1 |
| Gastpar, M | 1 |
| Schmitt, A | 1 |
| Schlösser, R | 1 |
| Schneider, F | 1 |
| Ohmann, C | 1 |
| Lewitzka, U | 1 |
| Gaebel, W | 1 |
| Möller, HJ | 1 |
| Riedel, M | 1 |
| Grippo, AJ | 1 |
| Beltz, TG | 1 |
| Johnson, AK | 1 |
| Capasso, R | 1 |
| Borrelli, F | 1 |
| Capasso, F | 1 |
| Mascolo, N | 1 |
| Izzo, AA | 1 |
| Waal, HJ | 1 |
| Fitzgerald, JD | 1 |
| Casacchia, M | 1 |
| Ianiri, G | 1 |
| Paykel, ES | 1 |
| Fleminger, R | 1 |
| Watson, JP | 1 |
| Cremona-Barbaro, A | 1 |
| Shader, RI | 1 |
| Greenblatt, DJ | 2 |
| Vardi, Y | 1 |
| Regev, I | 1 |
| Rosenbaum, M | 1 |
| Flechter, S | 1 |
| Noyes, R | 1 |
| Anderson, DJ | 1 |
| Clancy, J | 1 |
| Crowe, RR | 1 |
| Slymen, DJ | 1 |
| Ghoneim, MM | 1 |
| Hinrichs, JV | 1 |
| Wilbur, R | 1 |
| Kulik, AV | 1 |
| Shahid, A | 1 |
| Kirkegaard, C | 1 |
| Faber, J | 1 |
| Cohn, D | 1 |
| Kølendorf, K | 1 |
| Thomsen, HF | 1 |
| Lumholtz, IB | 1 |
| Siersbaek-Nielsen, K | 1 |
| Friis, T | 1 |
| McLane, M | 1 |
| Krop, H | 1 |
| Mehta, J | 1 |
| Iruela, LM | 1 |
| Gerstman, BB | 1 |
| Jolson, HM | 1 |
| Bauer, M | 1 |
| Cho, P | 1 |
| Livingston, JM | 1 |
| Platt, R | 1 |
| Verspeelt, J | 2 |
| De Locht, P | 2 |
| Amery, WK | 2 |
| Head, A | 1 |
| Kendall, MJ | 1 |
| Ferner, R | 1 |
| Eagles, C | 1 |
| Pérez-Stable, EJ | 1 |
| Halliday, R | 1 |
| Gardiner, PS | 1 |
| Baron, RB | 1 |
| Hauck, WW | 1 |
| Acree, M | 1 |
| Coates, TJ | 1 |
| Rudd, P | 1 |
| Cavallazzi, LO | 1 |
| Machado, SN | 1 |
| Matosinho, P | 1 |
| Pio, FJ | 1 |
| Hawken, ER | 1 |
| Delva, NJ | 1 |
| Lawson, JS | 1 |
| Kohn, R | 1 |
| Kabes, J | 1 |
| Dostal, T | 1 |
| Taussigová, D | 1 |
| Kabesová, L | 1 |
| Hawkings, JR | 1 |
| Burgess, CD | 1 |
| Turner, P | 1 |
| Wadsworth, J | 1 |
| Weiner, RD | 1 |
| Henschen, GM | 1 |
| Dellasega, M | 1 |
| Baker, JS | 1 |
| von Zerssen, D | 1 |
| Cording, C | 1 |
| Sandifer, MG | 1 |
| Suzman, MM | 1 |
| Carlsson, C | 1 |
| Fasth, BG | 1 |
| Heiser, JF | 1 |
| Defrancisco, D | 1 |
| Arushanian, EB | 1 |
| Beĭer, EV | 1 |
| Goble, AJ | 1 |
| Gelenberg, AJ | 1 |
| Thiessen, BQ | 1 |
| Wallace, SM | 1 |
| Blackburn, JL | 1 |
| Wilson, TW | 1 |
| Bergman, U | 1 |
| Martin, P | 1 |
| Massol, J | 1 |
| Colin, JN | 1 |
| Lacomblez, L | 1 |
| Puech, AJ | 1 |
| Koella, WP | 1 |
| Nakra, BR | 1 |
| Grossberg, GT | 1 |
| Hudson, CF | 1 |
| Wurzelmann, J | 1 |
| Frishman, WH | 1 |
| Aronson, M | 1 |
| Masur, D | 1 |
| Ooi, WL | 1 |
| Johnson, RH | 1 |
| Hornabrook, RW | 1 |
| Lambie, DG | 1 |
| Davis, BR | 1 |
| Furberg, CD | 1 |
| Williams, CB | 1 |
| Ziegler, DK | 1 |
| Hurwitz, A | 1 |
| Hassanein, RS | 1 |
| Kodanaz, HA | 1 |
| Preskorn, SH | 1 |
| Mason, J | 1 |
| Griffin, SJ | 1 |
| Friedman, MJ | 1 |
| Rosen, RC | 1 |
| Kostis, JB | 1 |
| Linken, A | 1 |
| Koch-Weser, J | 1 |
| Jefferson, JW | 1 |
| Ferrini, R | 1 |
| Miragoli, G | 1 |
| Croce, G | 1 |
| Simpson, FO | 2 |
| Hansson, L | 1 |
| Malmcrona, R | 1 |
| Olander, R | 1 |
| Rosenhall, L | 1 |
| Westerlund, A | 1 |
| Aberg, H | 1 |
| Hood, B | 1 |
| Cheah, JS | 1 |
| Wheatley, D | 1 |
| Waal-Manning, HJ | 1 |
| Roth, M | 1 |
| Myers, DH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Treat_CCM Clinical Trial A Multicenter Randomized Clinical Trial on Propranolol in Familial Cerebral Cavernous Malformation[NCT03589014] | Phase 2 | 71 participants (Actual) | Interventional | 2018-04-11 | Completed | ||
| A Pilot Trial of Galcanezumab for Vestibular Migraine[NCT04417361] | Phase 2 | 50 participants (Anticipated) | Interventional | 2020-09-18 | Recruiting | ||
| Maintenance Treatment vs. Stepwise Drug Discontinuation After One Year of Maintenance Treatment in First-Episode Schizophrenia[NCT00159120] | Phase 4 | 71 participants (Anticipated) | Interventional | 2001-11-30 | Completed | ||
| [NCT00000492] | Phase 3 | 0 participants | Interventional | 1977-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for propranolol and Depression
| Article | Year |
|---|---|
[What's new in pediatric dermatology in 2011?].
Topics: Attention; Child; Depression; Dermatologic Agents; Dermatology; Etanercept; Eye Diseases; Humans; Im | 2011 |
The management of cyclic vomiting syndrome: a systematic review.
Topics: Adrenergic beta-Antagonists; Age of Onset; Antidepressive Agents, Tricyclic; Depression; Female; Hea | 2012 |
Psychiatric side effects of antihypertensive drugs other than reserpine.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Anxiety; Bethanidine; Clonidine; Debrisoquin; | 1982 |
Beta-blockers an important cause of depression: a medical myth without evidence.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents; Antihypertensive Agents; Controlled Clinical Tri | 2001 |
CNS-related (side-)effects of beta-blockers with special reference to mechanisms of action.
Topics: Adrenergic beta-Antagonists; Amphetamine; Animals; Anxiety; Blood-Brain Barrier; Central Nervous Sys | 1985 |
Biobehavioral sequellae associated with adrenergic-inhibiting antihypertensive agents: a critical review.
Topics: Animals; Antihypertensive Agents; Cats; Cognition; Depression; Electroencephalography; Fatigue; Feed | 1985 |
Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston collaborative drug surveillance program.
Topics: Adrenergic beta-Antagonists; Bradycardia; Central Nervous System; Depression; Heart; Heart Failure; | 1974 |
Beta-adrenergic receptor blocking drugs in psychiatry.
Topics: Acute Disease; Adrenergic beta-Antagonists; Alcoholism; Amphetamine; Animals; Antidepressive Agents; | 1974 |
21 trials available for propranolol and Depression
| Article | Year |
|---|---|
Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial.
Topics: Adrenergic beta-Antagonists; Adult; Animals; Anxiety; Case-Control Studies; Depression; Disease Prog | 2020 |
Does Acute Propranolol Treatment Prevent Posttraumatic Stress Disorder, Anxiety, and Depression in Children with Burns?
Topics: Adolescent; Adrenergic beta-Antagonists; Anxiety; Burns; Child; Depression; Female; Follow-Up Studie | 2018 |
Propranolol and venlafaxine for vestibular migraine prophylaxis: A randomized controlled trial.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Depression; Female; Humans; Male; Middl | 2016 |
Preventing postsurgical dissatisfaction syndrome after rhinoplasty with propranolol: a pilot study.
Topics: Anxiety; Body Image; Depression; Double-Blind Method; Humans; Patient Satisfaction; Pilot Projects; | 2009 |
Akathisia and suicidal ideation in first-episode schizophrenia.
Topics: Adult; Age Factors; Akathisia, Drug-Induced; Antipsychotic Agents; Depression; Double-Blind Method; | 2012 |
Diazepam and propranolol in panic disorder and agoraphobia.
Topics: Adult; Agoraphobia; Anxiety Disorders; Clinical Trials as Topic; Depression; Diazepam; Double-Blind | 1984 |
Post-marketing cohort study comparing the safety and efficacy of flunarizine and propranolol in the prophylaxis of migraine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Basal Ganglia Diseases; Belgium; Child; Cohort Studies; | 1996 |
Acute effects of beta blockade and exercise on mood and anxiety.
Topics: Adrenergic beta-Antagonists; Adult; Affect; Age Factors; Anxiety; Body Weight; Confusion; Depression | 1996 |
The effects of propranolol on cognitive function and quality of life: a randomized trial among patients with diastolic hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Cognition; Depression; Diastole; | 2000 |
Cardiovascular responses to mianserin hydrochloride: a comparison with tricyclic antidepressant drugs.
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Bethanidine; Blood Pressure; Cardiovascular | 1978 |
Propranolol in the treatment of anxiety.
Topics: Adolescent; Adult; Aged; Anxiety; Clinical Trials as Topic; Depression; Female; Humans; Male; Middle | 1976 |
A comparison of the effects of propranolol and diazepam in alcoholics.
Topics: Adult; Alcoholism; Anxiety Disorders; Clinical Trials as Topic; Depression; Diazepam; Humans; Male; | 1976 |
An evaluation of once daily long acting propranolol hydrochloride (Inderal LA and Half-Inderal LA) in the treatment of anxiety. A double-blind placebo-controlled general practice study.
Topics: Adult; Anxiety; Clinical Trials as Topic; Delayed-Action Preparations; Depression; Double-Blind Meth | 1988 |
Comparison of mefenamic acid and propranolol with placebo in migraine prophylaxis.
Topics: Adult; Aged; Clinical Trials as Topic; Depression; Female; Gastrointestinal Diseases; Humans; Male; | 1986 |
Survival analysis of adverse effects data in the Beta-Blocker Heart Attack Trial.
Topics: Adult; Aged; Bronchial Spasm; Clinical Trials as Topic; Cross-Sectional Studies; Depression; Double- | 1987 |
Migraine prophylaxis. A comparison of propranolol and amitriptyline.
Topics: Adult; Amitriptyline; Anxiety; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; M | 1987 |
Beta-adrenergic receptor blocking drugs in psychiatry.
Topics: Acute Disease; Adrenergic beta-Antagonists; Alcoholism; Amphetamine; Animals; Antidepressive Agents; | 1974 |
Propranolol in hypertension. Report on 158 patients treated up to one year.
Topics: Adult; Aged; Airway Obstruction; Blood Pressure; Bradycardia; Clinical Trials as Topic; Creatinine; | 1972 |
Comparison between reserpine and propranolol as adjuncts in the treatment of hyperthyroidism.
Topics: Administration, Oral; Adult; Asthma; Basal Metabolism; Blood Pressure; Body Weight; Clinical Trials | 1973 |
Comparative effects of propranolol and chlordiazepoxide in anxiety states.
Topics: Anxiety Disorders; Chlordiazepoxide; Clinical Trials as Topic; Depression; Humans; Propranolol; Psyc | 1969 |
Psychopharmacology.
Topics: Alcoholism; Anxiety; Brain Damage, Chronic; Chronic Disease; Clinical Trials as Topic; Depression; E | 1970 |
48 other studies available for propranolol and Depression
| Article | Year |
|---|---|
Novel multitarget 5-arylidenehydantoins with arylpiperazinealkyl fragment: Pharmacological evaluation and investigation of cytotoxicity and metabolic stability.
Topics: Animals; Antidepressive Agents; Depression; Disease Models, Animal; Humans; Receptors, Serotonin; St | 2019 |
β-Blockers and the Risk of Depression: A Matched Case-Control Study.
Topics: Adrenergic beta-Antagonists; Case-Control Studies; Depression; Humans; Odds Ratio; Propranolol | 2022 |
Antidepressant-like deliverables from the sea: evidence on the efficacy of three different brown seaweeds via involvement of monoaminergic system.
Topics: Adrenergic Antagonists; Animals; Antidepressive Agents; Benzazepines; Depression; Dopamine Antagonis | 2017 |
Synthesis of new 1-phenyl-2-(4-substituted-piperazin-1-yl)-propanol derivatives and evaluation of their antidepressant-like effects.
Topics: Animals; Antidepressive Agents; Depression; Drug Evaluation, Preclinical; Hindlimb Suspension; Mice; | 2013 |
Increased depression, diabetes and diabetic complications in Graves' disease patients in Asia.
Topics: Adult; Aged; Antithyroid Agents; Cardiovascular Diseases; Cohort Studies; Depression; Diabetes Compl | 2014 |
The association between use of cardiovascular drugs and antidepressants: a nationwide register-based study.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Cardiovascular Agents; Cross-Sectional Studies; Depr | 2008 |
Postsynaptic alpha-2 adrenergic receptors are critical for the antidepressant-like effects of desipramine on behavior.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic beta-An | 2009 |
Distinct profiles of anxiety and dysphoria during spontaneous withdrawal from acute morphine exposure.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; | 2009 |
Evidence for the involvement of the serotonergic 5-HT2A/C and 5-HT3 receptors in the antidepressant-like effect caused by oral administration of bis selenide in mice.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Analysis of Varianc | 2010 |
Involvement of monoaminergic systems in the antidepressant-like effect of nobiletin.
Topics: Adrenergic Antagonists; Animals; Antidepressive Agents; Benzazepines; Cyproheptadine; Depression; Di | 2011 |
Behavioral and cardiovascular changes in the chronic mild stress model of depression.
Topics: Adrenergic beta-Antagonists; Animals; Behavior, Animal; Blood Pressure; Body Weight; Chronic Disease | 2003 |
Inhibitory effect of the antidepressant St. John's wort (hypericum perforatum) on rat bladder contractility in vitro.
Topics: Acetylcholine; Adenosine Triphosphate; Animals; Anthracenes; Antidepressive Agents; Atropine; Bridge | 2004 |
Propranolol-induced depression.
Topics: Arrhythmias, Cardiac; Depression; Humans; Hypertension; Propranolol | 1967 |
Propranolol-induced depression.
Topics: Depression; Humans; Hypertension; Propranolol | 1967 |
[Drug-induced depression].
Topics: Adrenal Cortex Hormones; Antipsychotic Agents; Contraceptives, Oral; Depression; Dihydroxyphenylalan | 1980 |
Propranolol and depression.
Topics: Depression; Female; Humans; Hypertension; Male; Middle Aged; Propranolol | 1983 |
Propranolol's psychiatric side effects.
Topics: Adrenergic beta-Antagonists; Depression; Humans; Mental Disorders; Propranolol | 1983 |
The behavioral effect of salbutamol (a beta-adrenergic receptor stimulant) on reserpine- and propranolol-treated rats.
Topics: Albuterol; Animals; Antidepressive Agents; Depression; Disease Models, Animal; Humans; Propranolol; | 1983 |
Abstinence syndrome from therapeutic doses of oxazepam.
Topics: Adult; Anxiety; Depression; Depressive Disorder; Diazepam; Fasciculation; Fear; Humans; Male; Oxazep | 1983 |
Propranolol in psychiatric illness.
Topics: Anxiety Disorders; Depression; Diagnosis, Differential; Humans; Panic; Propranolol | 1982 |
Serum 3'-monoiodothyronine levels in normal subjects and in patients with thyroid and non-thyroid disease.
Topics: Adult; Depression; Female; Humans; Hyperthyroidism; Hypothyroidism; Kidney Failure, Chronic; Male; M | 1981 |
Psychosexual adjustment and counseling after myocardial infarction.
Topics: Adult; Anxiety; Counseling; Depression; Humans; Male; Myocardial Infarction; Propranolol; Sexual Beh | 1980 |
Sudden chest pain with sertraline.
Topics: 1-Naphthylamine; Antidepressive Agents; Aspirin; Chest Pain; Coronary Disease; Depression; Humans; M | 1994 |
The incidence of depression in new users of beta-blockers and selected antihypertensives.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calc | 1996 |
Postmarketing study of the use of flunarizine in vestibular vertigo and in migraine.
Topics: Basal Ganglia Diseases; Betahistine; Cohort Studies; Depression; Female; Flunarizine; Histamine H1 A | 1996 |
The search for high-yield, low-risk antihypertensive treatment.
Topics: Adrenergic beta-Antagonists; Age Factors; Antihypertensive Agents; Cognition; Comorbidity; Confoundi | 2000 |
[Primary orthostatic tremor: report of 4 cases].
Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Arm; Clonazepam; Depression; Diagnosis, Differential; E | 2000 |
Successful use of propranolol in migraine associated with electroconvulsive therapy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Depression; Drug Therapy, Combination; Electroconvul | 2001 |
Proceedings: Clinical effects of beta-adrenergic blockers in psychiatry.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Anxiety; Depression; Humans; Mental Disorders; Middl | 1975 |
Clinical experience with beta-blockers in consultant psychiatric practice.
Topics: Adrenergic beta-Antagonists; Anxiety Disorders; Depression; Dose-Response Relationship, Drug; Drug E | 1975 |
Propranolol treatment of an ECT-related ventricular arrythmia.
Topics: Depression; Electroconvulsive Therapy; Heart Ventricles; Humans; Male; Middle Aged; Propranolol; Tac | 1979 |
The measurement of change in endogenous affective disorders.
Topics: Affect; Affective Symptoms; Circadian Rhythm; Depression; Dose-Response Relationship, Drug; Humans; | 1978 |
The hypertensive psychiatric patient: pharmacologic problems.
Topics: Antihypertensive Agents; Clonidine; Depression; Diuretics; Drug Interactions; Guanethidine; Humans; | 1978 |
Drugs for hypertension.
Topics: Antihypertensive Agents; Benzothiadiazines; Clonidine; Depression; Diuretics; Drug Combinations; Dru | 1977 |
The treatment of pathological panic states with propranolol.
Topics: Acute Disease; Adult; Agoraphobia; Anxiety Disorders; Chronic Disease; Depression; Depressive Disord | 1976 |
[The antidepressive properties of anaprilin].
Topics: Animals; Antidepressive Agents; Clonidine; Depression; Disease Models, Animal; Dose-Response Relatio | 1992 |
Beta-blocker treatment and depression.
Topics: Depression; Humans; Propranolol | 1992 |
Depression, depressants, and antidepressants.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents; Depression; Humans; Propranolol | 1990 |
Increased prescribing of antidepressants subsequent to beta-blocker therapy.
Topics: Adrenergic beta-Antagonists; Adult; Antidepressive Agents; Cohort Studies; Cross-Sectional Studies; | 1990 |
Antidepressant profile of bupropion and three metabolites in mice.
Topics: Animals; Antidepressive Agents; Apomorphine; Body Temperature; Bupropion; Depression; Male; Mice; Mo | 1990 |
Management of anxiety in the elderly.
Topics: Aged; Anti-Anxiety Agents; Anxiety; Depression; Diagnosis, Differential; Female; Humans; Male; Propr | 1986 |
Neuropsychological effects of antihypertensive drugs.
Topics: Affect; Aged; Aged, 80 and over; Antihypertensive Agents; Cognition Disorders; Depression; Female; H | 1987 |
Depressive symptoms in propranolol users.
Topics: Administration, Oral; Age Factors; Aged; Cardiovascular Diseases; Depression; Depressive Disorder; H | 1986 |
Propranolol for L.S.D.-induced anxiety states.
Topics: Anxiety Disorders; Depression; Humans; Lysergic Acid Diethylamide; Male; Propranolol; Psychoses, Sub | 1971 |
Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent.
Topics: Adrenergic beta-Antagonists; Amphetamine; Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Antic | 1970 |
Editorial: Hypertension and depression and their treatment.
Topics: Animals; Antidepressive Agents; Antihypertensive Agents; Clonidine; Depression; Humans; Hypertension | 1973 |
Hypertension and depression: interrelated problems in therapy.
Topics: Antidepressive Agents; Antihypertensive Agents; Depression; Humans; Hypertension; Methyldopa; Physic | 1971 |
Anxiety neuroses and phobic states. II. Diagnosis and management.
Topics: Antidepressive Agents; Anxiety Disorders; Depression; Diagnosis, Differential; Female; Humans; Hypno | 1969 |